Health Novel Antihypertensive Stumbles Over Early-Phase Hurdle James Pereira Mar 5, 2023 NEW ORLEANS -- A phase II trial with baxdrostat failed to… Read More...
Health Another Class of Antihypertensive Recalled James Pereira Mar 26, 2022 This week, Pfizer launched… Read More...
Health Antihypertensive Add-On Has Edge Over Boosting Doses James Pereira Oct 5, 2021 While adding an agent was… Read More...
Health Among Antihypertensive Drugs, Less Popular Drugs Found Safer James Pereira Jul 27, 2021 "But our study shows that ARBs are associated with fewer side effects than ACE inhibitors. The study focused on… Read More...